Takenori Niioka

15PUBLICATIONS
4CO-AUTHORS
PharmacogenomicsEpidemiological modellingInstrumental methods (excl. immunological and bioassay methods)Medical infection agents (incl. prions)Pharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 17, 2026
Impact of SLCO1B1 Gene Polymorphisms on Vadadustat Pharmacokinetics.

|Jun 16, 2026
A Simplified Limited-Sampling Strategy for Accurate Prediction of Doxorubicin and Doxorubicinol Exposure.

|Apr 17, 2026
Comparison of an HPLC-UV system (LM1010) and UPLC-MS/MS for plasma voriconazole measurement in routine clinical practice.

|Apr 04, 2025
Influence of Polymorphisms in Pharmacokinetics-Related Genes on the Areas Under the Plasma Concentration-Time Curves of Doxorubicin and Doxorubicinol in Patients with Diffuse Large B-Cell Lymphoma Receiving CHOP Therapy.

Keigo Saito, Takenori Takahata, Junichi Nakagawa

|Oct 29, 2024
Abnormally high plasma concentrations of M-4, the active metabolite of edoxaban, at the onset of acute kidney injury in a patient receiving rifampin and clarithromycin: a case report.

Junichi Nakagawa, Keinosuke Ishido, Norihisa Kimura

|Jul 02, 2024
Quantification of the Plasma Concentration of Vadadustat by High-Performance Liquid Chromatography with Ultraviolet Detection and Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry.

Satoshi Yokoyama, Junichi Nakagawa, Michiko Shimada

Pageof 3

Frequent Collaborators

3 joint publications

Junichi Nakagawa

3 joint publications

Satoshi Yokoyama

2 joint publications

Naoya Aiuchi

1 joint publications

Keigo Saito